Endocuff辅助与标准结肠镜检查在日常实践中的腺瘤检出率:整群随机交叉试验
该整群随机交叉试验比较Endocuff Vision辅助结肠镜(ECV+)与标准结肠镜(ECV-)对腺瘤检出率(ADR)的影响,22名经验内镜医师共纳入2058例患者。ECV+组整体ADR为39.2%,显著高于ECV-组的29.4%(p<0.001),但亚组分析显示仅高检出率医师(ADR≥25%)的ADR提升显著(31%升至41%,p<0.001),低检出率医师提升不显著(24%升至30%,p=0.11)。
要点
- ECV辅助结肠镜使整体ADR从29.4%提升至39.2%,差异约10%。
- 仅高检出率医师(基线ADR≥25%)的ADR提升显著,低检出率医师提升不显著。
- ECV对除直肠外的所有结肠部位均有积极影响,且无相关并发症报告。
核心结论
- 使用ECV可使整体ADR提高约10个百分点,但该提升仅在基线高检出率医师中具有统计学显著性。
研究设计与样本
- 整群随机交叉试验,比较ECV辅助与标准结肠镜,两 teams 各11名有ECV经验的内镜医师,按基线ADR、性别和病例量平衡。
- 共纳入2058例患者(ECV-组1032例,ECV+组1026例),两组基线可比,研究分两个阶段(20周和21周)交叉进行。
主要发现
- 整体ADR在ECV+组为39.2%,ECV-组为29.4%(p<0.001),差异不受使用顺序影响,但主要见于小于1 cm的腺瘤。
- 高检出率医师亚组ADR从31%升至41%(p<0.001),低检出率医师从24%升至30%(p=0.11),差异不显著。
- ECV对所有结肠部位(直肠除外)均有积极影响,未报告ECV相关并发症。
关键数值与推荐
- 主要结局指标为ECV+与ECV-之间的ADR差异。
- 亚组分析按医师基线ADR分为低(<25%)和高(≥25%)两组。
临床怎么用
- 在日常结肠镜实践中,ECV辅助可提高整体ADR,但获益主要集中在基线高检出率医师,低检出率医师的增益有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Endocuff Vision (ECV) is the second generation of a device designed to improve polyp detection. The aim of this study was to evaluate its impact on adenoma detection rate (ADR) in routine colonoscopy. DESIGN: This cluster-randomised crossover trial compared Endocuff-assisted (ECV+) with standard (ECV-) colonoscopy. Two teams of 11 endoscopists each with prior ECV experience, balanced in terms of basal ADR, gender and case volume were compared. In randomised fashion, the teams started with ECV+ or ECV- and switched group after inclusion of half of the cases. The main outcome criterion was ADR difference between ECV+ and ECV-. Subgroup analysis was done for physicians with low and high ADR (< or ≥ 25%). RESULTS: During two periods of 20 and 21 weeks, respectively, the 22 endoscopists included 2058 patients (1032 ECV- vs 1026 ECV+, both groups being comparable). Overall ADR for both groups taken together was higher with ECV (39.2%) than without (29.4%; p<0.001) irrespective of the sequence of use (ECV+ or ECV- first), but mostly in adenomas <1 cm. In the physician subgroup analysis, only high detectors showed a significant ADR increase (from 31% to 41%, p<0.001), while the increase in the low detectors was not significant (from 24% to 30%, p=0.11). ECV had a positive impact in all colonic locations, except for the rectum. No ECV- related complication was reported. CONCLUSION: We observed a significant ADR difference of approximately 10% by the use of ECV. By subgroup analysis, this increase was significant only in physicians classified as high detectors. TRIAL REGISTRATION NUMBER: ClinicalTrials.gov (NCT03344055).
引用
- Karsenti D, Tharsis G, Perrot B, et al. Adenoma detection by Endocuff-assisted versus standard colonoscopy in routine practice: a cluster-randomised crossover trial. Gut. 2020. PMID: 32209605. doi:10.1136/gutjnl-2019-319565
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。